Search for: "BRISTOL-MYERS (PRIVATE) LIMITED" Results 1 - 20 of 26
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Apr 2021, 9:45 am by anne
How to Blow the Whistle on Improper AMP Calculations and other Medicaid Drug Rebate Fraud The case against Bristol-Myers was brought under the False Claims Act, a law that allows private persons to sue those defrauding the government and share in the recovery. [read post]
5 Apr 2011, 8:38 pm by Dale Carpenter
 to join Bristol Myers Squibb and GlaxoSmithKline in their efforts to prevent the illegal production of patented AIDS drugs in Africa? [read post]
5 Apr 2011, 6:01 pm by Thom Lambert
  to join Bristol Myers Squibb and GlaxoSmithKline in their efforts to prevent the illegal production of patented AIDS drugs in Africa? [read post]
19 Jun 2014, 8:11 am
TAP Pharmaceuticals (Bristol Myers Squibb Appeal), No. 85 MAP 2011, slip op. [read post]
21 Jun 2017, 4:26 am by Edith Roberts
” Briefly: At The George Washington Law Review’s On the Docket blog, Alan Morrison looks at Monday’s decision in Bristol-Myers Squibb Co. v. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
Virtual communication technologies may include, but are not limited to, videoconferencing platforms such as Zoom, Skype and Microsoft Teams, internal chat functions and, in some cases, external chat functions through social media platforms such as LinkedIn. [read post]
29 Jun 2016, 6:13 am by Barry Sookman
The Plaintiffs make a strong prima facie case that the Defendants, through their products and advertising, sanction and encourage accessing copyrighted content through streaming sites or private IPTV services. [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch)… [read post]
31 Dec 2015, 5:12 am
  Celexa was the first appellate decision recognizing that Mensing (2011 +1) impossibility preemption cannot be limited to generic drugs. [read post]
21 Jun 2012, 7:40 am by Bexis
Bristol-Myers Squibb Co., 2009 WL 5216982, at *5-6 (D.N.J. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]